ORPHAN
Dead / Cancelled — Cancelled — Section 8 (as of 28 Nov 2014)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 76207867
- Registration number
- 3414817
- Mark type
- Design + words
- Filed
- 09 Feb 2001
- Published for opposition
- 28 Nov 2006
- Registered
- 22 Apr 2008
- Attorney of record
- Michael W. Garvey
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals for the treatment of rare diseases, namely, in the field of cardiology, diseases affecting immunocompromised patients, genetic disorders, haematology, infectious diseases, metabolic disorders, oncology, pallative care, poison control, respiratory diseases, urology and psychiatric diseases
- Class 042 — Scientific and technological services: product research and development of prescription and over-the-counter drugs
Owner
- Swedish Orphan International AB, Stockholm, SE
- Swedish Orphan International AB, Stockholm, SE
- Orphan Pharmaceuticals-USA, Inc., Nashville, TN, US
- Orphan Pharmaceuticals, U.S.A., Inc., Nashville, TN, US
Prosecution history
- 28 Nov 2014 — CANCELLED SEC. 8 (6-YR)
- 09 Sept 2008 — CORRECTION UNDER SECTION 7 - PROCESSED
- 09 Jun 2008 — ASSIGNED TO PARALEGAL
- 06 May 2008 — SEC 7 REQUEST FILED
- 06 May 2008 — PAPER RECEIVED
- 22 Apr 2008 — REGISTERED-PRINCIPAL REGISTER
- 14 Mar 2008 — LAW OFFICE REGISTRATION REVIEW COMPLETED
- 14 Mar 2008 — ASSIGNED TO LIE
- 22 Feb 2008 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 04 Dec 2007 — STATEMENT OF USE PROCESSING COMPLETE
- 13 Nov 2007 — USE AMENDMENT FILED
- 13 Nov 2007 — TEAS STATEMENT OF USE RECEIVED
- 08 Aug 2007 — SOU EXTENSION 1 GRANTED
- 08 Aug 2007 — SOU EXTENSION 1 FILED
- 08 Aug 2007 — SOU TEAS EXTENSION RECEIVED